Global

New retail outlet said to be first one located in a major transportation hub around the globe

Flagship product from company's medical cannabis division now set for clinical trial use

Prominent speaker lineup promised for 'the largest cannabis investing and finance event' this September

Clinical psychedelic sector value anticipated to ascend significantly into 2028

Company set to showcase legal cannabis in North America yet again

Country known for high-end automobiles, Oktoberfest and a strong economy may soon join countries who have legalized cannabis

Company growth within Colombia and Europe responsible for financial success this quarter

Report outlines environmental, social and governance (ESG) priorities for the emerging global industry

The market is expected to surge due to CBD's medicinal and healing effects

The Canadian cannabis giant says it's also invested in forest conservation and reducing ocean-bound plastics

Current legal markets have been captured by corporations and fail to address the racist war on drugs, the International Drug Policy Consortium warns

The pot stock popped 36 per cent this week while reporting $0.04 a gram production costs in Colombia

Tom Adams of BDS Analytics says stocks will by buoyed by global legal cannabis sales reaching US$42.7 billion in five years

The Ontario producer will be able to ship anywhere inside the 28-member European Union

Tissue culture uses less space and labour than the traditional trimming cloning method

The marijuana titan expands its international presence with operations in a total of 12 countries by adding the two European nations.

Chinese visitors warned about "harmfulness" of weed, cautioned to read product labels thoroughly to avoid accidentally smuggling pot products into China

Ikänik Farms is looking to go public in the next several months, and CEO Brian Baca tells Mugglehead its Pideka acquisition will "crush everybody coming out of Canada" with its low-cost cultivation and export potential.

“Weediatrics: A Covert Medical Mission” shows how American parents who need medical cannabis for their sick or disabled children are forced to break federal laws.

The former heavyweight champion is investing in cannabis tourism on the two-island nation Antigua and Barbuda and plans to host an annual cannabis conference to boost island tourism.

Mugglehead speaks with MediPharm president Keith Strachan about how the cannabis extraction pioneer is gearing up for the launch of Cannabis 2.0 products in Canada.

While investors brace for cannabis companies to post quarterly losses, the Barrie, Ont.-based pot extractor reported a second-quarter profit ahead of the launch of Cannabis 2.0 products.

Tiny Luxembourg could have a big effect on cannabis legalization in the European Union and open up the market for pot once the country goes recreational in two years.

The B.C.-based pot company adds nearly 50 acres of outdoor production in Portugal to further supply the European Union medical cannabis market.

A Tel Aviv-based team at Weedley is launching several clinical studies to test if CBD is an effective and safe way to treat pain in dogs and horses.

The Ontario-based company's subsidiary Marigold Projects was granted a retail licence from Jamaican authorities and it plans to open four more pot shops, pending further approval.

The British-based tobacco firm and the Canadian pot company say the sizeable deal will help both execute their global cannabis vape plans.

The Calgary-based company announced terms and aims to raise US$130 million with its initial public offering on the Nasdaq.

The deal will give Supreme access to Truverra's 5,000 square-foot licensed facility the company plans to turn into a state-of-the-art extraction lab to develop next-generation cannabis products.

The Edmonton-based pot producer will supply 400 kilograms of medical cannabis to Italy under the contract, but securing the bid at $2.54 per gram may actually hurt Aurora's bottom line.

BDS Analytics and Arcview Market Research predict the global cannabis market will reach US$14.9 billion this year and US$40.6 billion by 2024.

Ireland's Health Minister signed legislation last week which will allow citizens to gain limited access to medical cannabis to treat multiple sclerosis, chemotherapy-related illness and epilepsy.

It took eight years and $83 million dollars for Tel Aviv-based Syqe Medical to develop the new product that will allow medical marijuana patients to take accurate doses.

A loophole in a 2016 law to support hemp farmers has created an opportunity for hundreds of stores to open and sell low-potency pot across the European nation.